Autolus Therapeutics Stock (NASDAQ:AUTL), Quotes and News Summary

Q: What sector and industry does Autolus Therapeutics (AUTL) operate in?

Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.

Open	$4.180
Close	$4.080
Volume / Avg.	3.873M / 1.561M
Day Range	3.960 - 4.290
52 Wk Range	1.610 - 7.450
Market Cap	$1.138B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	27
Short Interest	2.12%
Days to Cover	4.95

Recent News

Autolus Therapeutics' Obe-Cel's Shows Compelling Safety Over Gilead's Drug For Acute Lymphoblastic Leukemia

Truist has raised the price target for Autolus Therapeutics PLC (NASDAQ: AUTL) from $6 to $9

Vandana Singh

Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.

Lisa Levin

Sarepta Therapeutics, C3.ai, monday.com, And Other Big Stocks Moving Higher On Monday

U.S. stocks traded lower, with the Dow Jones dropping around 100 points on Monday. Here are some big stocks recording gains in today’s session.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Jan

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Autolus Therapeutics plc

Sector

Health Care

Industry

Biotechnology

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Autolus Therapeutics (AUTL) stock?

You can purchase shares of Autolus Therapeutics (NASDAQ: AUTL) through any online brokerage.

View our list of the best stock brokerages.

Who are Autolus Therapeutics's (AUTL) competitors?

Other companies in Autolus Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), 4D Molecular Therapeutics (NASDAQ:FDMT), Centessa Pharmaceuticals (NASDAQ:CNTA), Prothena Corp (NASDAQ:PRTA) and Immatics (NASDAQ:IMTX).

What is the target price for Autolus Therapeutics (AUTL) stock?

The latest price target for Autolus Therapeutics (NASDAQ: AUTL) was reported by Needham on Friday, April 12, 2024. The analyst firm set a price target for 9.00 expecting AUTL to rise to within 12 months (a possible 110.28% upside). 16 analyst firms have reported ratings in the last year.

Current Stock Price for Autolus Therapeutics (AUTL)?

The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $4.28 last updated April 25, 2024 at 7:59 PM EDT.

Does Autolus Therapeutics (AUTL) pay a dividend?

There are no upcoming dividends for Autolus Therapeutics.

When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?

Autolus Therapeutics’s Q1 earnings are confirmed for Tuesday, May 14, 2024.

Is Autolus Therapeutics (AUTL) going to split?

There is no upcoming split for Autolus Therapeutics.

What sector and industry does Autolus Therapeutics (AUTL) operate in?

Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-